The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum]

Gareri P, Castagna A, Cotroneo AM, Putignano S, De Sarro G, Bruni AC. Clin Interv Aging. 2015;10:1421–1429.On page 1423, Figure 2 Citicoline’s metabolic pathways, please note that this figure has been modified to include: Adibhatla RM, Hatcher JF, Dempsey RJ. Effects of citicolin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gareri P, Castagna A, Cotroneo AM, Putignano S, De Sarro G, Bruni AC
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/7dae5f0708694c12a78b84b1504d1d15
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7dae5f0708694c12a78b84b1504d1d15
record_format dspace
spelling oai:doaj.org-article:7dae5f0708694c12a78b84b1504d1d152021-12-02T07:29:19ZThe role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum]1178-1998https://doaj.org/article/7dae5f0708694c12a78b84b1504d1d152015-10-01T00:00:00Zhttps://www.dovepress.com/corrigendum-the-role-of-citicoline-in-cognitive-impairment-pharmacolog-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Gareri P, Castagna A, Cotroneo AM, Putignano S, De Sarro G, Bruni AC. Clin Interv Aging. 2015;10:1421–1429.On page 1423, Figure 2 Citicoline’s metabolic pathways, please note that this figure has been modified to include: Adibhatla RM, Hatcher JF, Dempsey RJ. Effects of citicoline on phospholipid and glutathione levels in transient cerebral ischemia. Stroke. 2001;32(10):2376–2381.Read the original articleGareri PCastagna ACotroneo AMPutignano SDe Sarro GBruni ACDove Medical PressarticleGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 10, Pp 1625-1626 (2015)
institution DOAJ
collection DOAJ
language EN
topic Geriatrics
RC952-954.6
spellingShingle Geriatrics
RC952-954.6
Gareri P
Castagna A
Cotroneo AM
Putignano S
De Sarro G
Bruni AC
The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum]
description Gareri P, Castagna A, Cotroneo AM, Putignano S, De Sarro G, Bruni AC. Clin Interv Aging. 2015;10:1421–1429.On page 1423, Figure 2 Citicoline’s metabolic pathways, please note that this figure has been modified to include: Adibhatla RM, Hatcher JF, Dempsey RJ. Effects of citicoline on phospholipid and glutathione levels in transient cerebral ischemia. Stroke. 2001;32(10):2376–2381.Read the original article
format article
author Gareri P
Castagna A
Cotroneo AM
Putignano S
De Sarro G
Bruni AC
author_facet Gareri P
Castagna A
Cotroneo AM
Putignano S
De Sarro G
Bruni AC
author_sort Gareri P
title The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum]
title_short The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum]
title_full The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum]
title_fullStr The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum]
title_full_unstemmed The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [Corrigendum]
title_sort role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives [corrigendum]
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/7dae5f0708694c12a78b84b1504d1d15
work_keys_str_mv AT garerip theroleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum
AT castagnaa theroleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum
AT cotroneoam theroleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum
AT putignanos theroleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum
AT desarrog theroleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum
AT bruniac theroleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum
AT garerip roleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum
AT castagnaa roleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum
AT cotroneoam roleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum
AT putignanos roleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum
AT desarrog roleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum
AT bruniac roleofciticolineincognitiveimpairmentpharmacologicalcharacteristicspossibleadvantagesanddoubtsforanolddrugwithnewperspectivescorrigendum
_version_ 1718399410746949632